Science Explorer Interactive view Map
Institution · Amsterdam · Netherlands

Hovon

Research works
37
▲ 11% vs 2013–17
Citations
975
26.7 per fractional work
Top-10% rate
24.6%
record average 16.5%
Open access
53%
world 28%

Not ranked overall: Hovon is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.51× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.66× its world share, 0 worksImmunology and Micro…Neuroscience: 0.84× its world share, 0 worksNeuroscienceChemistry: 3.08× its world share, 0 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEnergy: 0.66× its world share, 0 worksEnergyEngineering: 0.85× its world share, 1 worksEngineeringEnvironmental Science: 0.36× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.52× its world share, 0 worksMaterials ScienceMathematics: 1.78× its world share, 0 worksMathematicsHealth Professions: 1.08× its world share, 0 worksHealth ProfessionsMedicine: 2.79× its world share, 5 worksMedicineNursing: 2.77× its world share, 0 worksNursingArts and Humanities: 0.47× its world share, 0 worksArts and HumanitiesDecision Sciences: 0.78× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.57× its world share, 0 worksEconomics, Econometr…Psychology: 0.30× its world share, 0 worksPsychologySocial Sciences: 0.21× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Chemistry, 3.1×. Every wedge is a field page.

Which keywords describe research at Hovon?

By fractional works in all years, weighted toward what it does more of than the world: Prognostic Factors, Rituximab, Minimal Residual Disease, Lymphoma, Hematopoietic Stem Cells, PET Imaging, Proteasome Inhibitors and Diagnosis Criteria.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Prognostic Factors4▲ 27×7 topics
  2. Rituximab4▲ 65×2 topics
  3. Minimal Residual Disease3▲ 118×2 topics
  4. Lymphoma3▲ 51×2 topics
  5. Hematopoietic Stem Cells3▲ 70×3 topics
  6. PET Imaging2▲ 30×3 topics
  7. Proteasome Inhibitors2▲ 89×2 topics
  8. Classification2▲ 16×1 topic
  9. Diagnosis Criteria2▲ 193×1 topic
  10. International Myeloma Working Group2▲ 193×1 topic
  11. Molecular Profiling2▲ 47×1 topic
  12. Metal-Catalyzed Reactions2▲ 60×2 topics
  13. Therapeutic Targets2▲ 21×2 topics
  14. Chronic Lymphocytic Leukemia2▲ 98×1 topic
  15. Genomic Aberrations2▲ 98×1 topic
  16. Transition Metal Catalysis2▲ 33×3 topics
  17. AML2▲ 89×1 topic
  18. Acute Myeloid Leukemia2▲ 89×1 topic
  19. Chemotherapy1▲ 5.5×10 topics
  20. Enantioselective Synthesis1▲ 23×3 topics
  21. Heterocycles1▲ 21×2 topics
  22. Transition Metal Complexes1▲ 30×3 topics
  23. Bone Marrow Niche1▲ 86×1 topic
  24. Carbon–Carbon Bond Formation1▲ 64×1 topic
  25. Catalysis1▲ 3.6×5 topics
  26. C–H Activation1▲ 64×1 topic
  27. Graft-versus-Host Disease1▲ 86×1 topic
  28. Hydrogenation1▲ 14×3 topics
  29. Indo-European1▲ 105×1 topic
  30. Linguistics1▲ 23×1 topic

Which research topics does Hovon publish most on?

By volume in 2022–2025: Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Multiple Myeloma Research and Treatments and Chronic Lymphocytic Leukemia Research.

  1. 1 Acute Myeloid Leukemia Research Hematology 1 works
  2. 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  3. 3 Multiple Myeloma Research and Treatments Hematology 0 works
  4. 4 Chronic Lymphocytic Leukemia Research Genetics 0 works
  5. 5 CAR-T cell therapy research Oncology 0 works
  6. 6 Process Optimization and Integration Control and Systems Engineering 0 works
  7. 7 Advanced Optical Network Technologies Electrical and Electronic Engineering 0 works
  8. 8 Vehicle Routing Optimization Methods Industrial and Manufacturing Engineering 0 works
  9. 9 Intraperitoneal and Appendiceal Malignancies Surgery 0 works
  10. 10 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.0%not open47.0%

World: 28% of research is openly available.

with international co-authors55.0%domestic only45.0%

World: 19% is written across borders.

How has Hovon's research output changed?

Output in 2018–2022 was 11% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Amsterdam

All research institutions in Amsterdam

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.